Latest News and Press Releases
Want to stay updated on the latest news?
-
Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing
-
Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing
-
Seed raise exceeding 200% of target positions the DebitMyData Digital Identity LLM (DID-LLM) for Global Partnerships and Licensing
-
NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned...
-
Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s HMBD-002 for further clinical development
-
LOS ANGELES, June 16, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most...
-
Medicovestor and Sanyou team up to develop first-in-class chemoimmunotherapy ADCs, combining AI antibody tech with novel dual-targeting platforms.
-
LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, today announced that it remains fully operational and is actively working...
-
LOS ANGELES, May 30, 2025 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most...
-
The program, licensed exclusively to BMS, represents the third ADC candidate using the company’s proprietary Tubutecan technology to reach the clinic. MUNICH, GERMANY, May 20, 2025 – Tubulis today...